Clinical Decision Support Systems - Market Insights, Competitive Landscape, and Market Forecast - 2030

Clinical Decision Support Systems Market By Model Type (Knowledge-Based CDSS And Non-Knowledge CDSS), By Mode Of Delivery (Cloud-Based And On-Premise), By Component Type (Hardware, Software, And Services), By Product Type (Integrated CDSS And Standalone CDSS), By Application (Medical Diagnosis, Alerts And Reminders, Prescription Decision Support, Information Retrieval, And Other Applications), By End-User (Hospital And Clinics, Ambulatory Surgical Centers, And Others), by geography is expected to grow at a steady CAGR forecast till 2030 owing to increasing patient pool globally due to increasing prevalence of chronic ailments such as hypertension, diabetes, and others and the surging need for improvement in the quality of care of patient

Global clinical decision support systems (CDDS) market was valued at USD 2.23 billion in 2023, growing at a CAGR of 6.62% during the forecast period from 2024 to 2030 to reach USD 3.28 billion by 2030. The increase in demand for clinical decision support systems is primarily attributed to the increasing pool of patients due to the increasing prevalence of chronic disorders and due to unhealthy lifestyle and habits. Moreover, the surging need by patients for improvement in the quality of patient care will bolster the market of the clinical decision systems in the study period. Furthermore, the growing demand of intelligent software solutions in the healthcare sector globally, will increase the demand of the CDDS. Additionally, the CDDS may provide a remote patient care which will decrease the number of hospitalization of patients, thereby reducing the overall healthcare expenditure. Thus, the need to reduce the healthcare expenditure across the world is anticipated to bolster the market, thereby contributing to the growth of the clinical decision support systems market during the forecast period from 2024-2030.

Clinical Decision Support Systems Market Dynamics:

The clinical decision support systems market is witnessing a growth in product demand owing to various reasons.

The increasing patient pool worldwide, is demanding for the improvement in patient care. The patient care can be improvised by even monitoring the patient's health remotely and by collecting and analyzing the real-time as well as continuous data of the patient's health. After analyzing continuous data of the patient, the treatments/prognosis of the diseases can be done accordingly. For instance, the increasing prevalence of cardiovascular disorders such as, heart failure and stroke worldwide owing to various factors such as, genetic, age, obesity, unhealthy lifestyles and increasing number of geriatric patients that are prone to chronic disorders across the world are anticipated to bolster the market.

According to the World Health Organization (WHO) 2022, in 2019, cardiovascular diseases (CVDs) was one of the leading cause of death globally. It was estimated that around 17.9 million people died from CVDs in 2019, representing 32% of all global deaths. It was also estimated that out of 17.9 million deaths, 85% of the deaths were due to heart attack and stroke. Additionally, as per the same source, it was concluded that over three quarters of CVD deaths take place in low- and middle-income countries. WHO had concluded that most of the cardiovascular diseases can be prevented by addressing behavioral risk factors such as tobacco use, unhealthy diet and obesity, physical inactivity and harmful use of alcohol. Additionally, the prevalence of heart failure is also rising. According to the Global Health Data Exchange 2019, it was estimated that globally 64.37 million people were suffering from heart failure. In this case, the condition of heart, blood pressure, heart rate, and other thing can be monitored by a physician remotely using a clinical decision support system, and then the physician can amend the treatment according the patient's condition. Thus, the increasing patient number globally will increase the demand of the clinical decision support system, thereby can be anticipated to bolster the overall market growth in the study period of 2022 - 2028.

Moreover, according to WHO 2022, by 2030, one in six people in the world will be aged 60 years or over. The share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion globally. By 2050, the world's population of people aged 60 years and older will double (2.1 billion). The number of person aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million. Thus, the number of geriatric population is increasing which will in turn will affect the prevalence of chronic ailments as age is one of the major risk factor for these disorders. The increased prevalence of chronic disorder will ultimately increase the overall patient pool, thereby leading to the increased demand of the clinical decision support system in the market. Hence, the above factor will bolster the market of clinical decision support systems in the forecast period.

Moreover, the product launches in local market, and continuous government support, will in turn, drive the product demand in the market. For instance, in April 2022, Change Healthcare, a leading healthcare technology company, announced the unveiled InterQual® 2022, the latest edition of the company's flagship clinical decision support solution. The new release features four new Medicare criteria modules in addition to a significant number of evidence-based content updates and enhancements, including new guidance on caring for COVID-19 patients, addressing social determinants of health, and the appropriate use of telehealth.

Thus, due to the increasing patient number globally, increasing prevalence of chronic disorders and product launches, will pay way to a rising demand for clinical decision support systems, in turn increasing the clinical decision support systems market growth.

However, higher costs of software installations and post-sale supports and the data security concerns related to cloud based systems may hinder the overall market growth of the clinical decision support systems.

The ongoing COVID-19 pandemic has amplified the market for clinical decision support systems as during the pandemic the patients had preferred clinical decision support system to reduce the transmission of the infection. Hospitals were booked globally due to a huge number of patients that were suffering from the infection. Due to this, patients suffering from other disorders were not able to get treatment and beds in the hospitals, thereby leading to serious conditions and even death. This factor increased the demand of the clinical decision support systems as these systems provides clinical treatment to the patients and even help in reducing the risk of transmission of the infection. The CDDS systems are also very effective for geriatric and bed-ridden patients. The system was also helpful in providing the healthcare services in remote areas. Thus, the above factor was responsible for the sky-rocketed demand of the system in the year 2023, and the same factor is anticipated to bolster the overall market, globally of clinical decision support system in the forecast period of 2022 - 2028.

Clinical Decision Support Systems Market Segment Analysis:

Clinical Decision Support Systems Market by Model Type (Knowledge-Based CDSS and Non-Knowledge CDSS), by Mode Of Delivery (Cloud-Based and On-Premise), by Component Type (Hardware, Software, and Services), by Product Type (Integrated CDSS and Standalone CDSS), by Application (Medical Diagnosis, Alerts and Reminders, Prescription Decision Support, Information Retrieval, and Other Applications), by End User (Hospital And Clinics, Ambulatory Surgical Centers, and Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the mode of delivery segment of the clinical decision support systems market, the cloud-based clinical decision support systems are estimated to hold a significant share in the clinical decision support systems market during the forecast period (2024-2030). This can be ascribed to the various advantages that are associated with the segment.

The most important benefit of cloud-based clinical decision support systems is that it reduces the medication error. Errors involving drug-drug interactions (DDI) are cited as common and preventable. CDSS systems are now designed with drug safety software that has safeguards for dosing, duplication of therapies, and DDI checking. The system generates alerts when any error is observed. The system ensures patient safety by reducing the medication errors.

Additionally, the CDSS can take a variety of forms, from standardized order sets for a targeted case, alerts to a specific protocol for the patients it pertains to, reminders for testing, etc.

Furthermore, CDSS can assist with managing patients on research/treatment protocols, tracking and placing orders, follow-up for referrals, as well as ensuring preventative care. Also, the CDSS can also alert clinicians to reach out to patients who have not followed management plans, or are due for follow-up.

Moreover, the CDSS can be cost-effective for health systems, through clinical interventions as it is responsible for decreasing inpatient length-of-stay. The cloud-based integrated systems suggests cheaper medication alternatives, and reduces test duplication.

Further, the cloud-based knowledge-based imaging CDSS are typically used for image ordering, where CDSS can aid radiologists in selecting the most appropriate test to run, providing reminders of best practice guidelines, or alerting contraindications to contrast.

Thus, owing to the various advantages in the area of cloud-based clinical decision support systems, there will be an increase in the demand for cloud-based clinical decision support systems, which in turn will drive the clinical decision support systems market growth.

North America is expected to dominate the overall Clinical Decision Support Systems Market:

Among all the regions, North America is expected to account for the significant share in the global clinical decision support systems market.

Increasing patient pool in the region and the rising need in the improvement of the quality of the patient care will increase the product demand in the North America. Further, the increasing prevalence of chronic disorders such as diabetes, cardiovascular disorders, hypertension, infections, and many more due to high consumption of processed food & lifestyle changes, and growing incidence of obesity is anticipated to overall propel the market growth of the system in the region. Additionally, an increasing number of geriatric population susceptible to chronic medical ailments such as diabetes, neurological disorders, and cardiovascular diseases, and others will increase the demand for clinical decision support systems in North America, leading to a rise in the overall clinical decision support systems market growth.

For instance, as per the data published by the International Diabetes Federation (IDF), Diabetes Atlas Tenth edition 2022, in the year 2023, approximately 51 million adults (20-79 years) were living with diabetes in North America and the total number of people living with diabetes is projected to rise to 7 million by 2030 and 63 million by the year 2045. As per the same source, it was estimated that in 2022 almost 1 in 4 (240 million) adults living in North America with diabetes were undiagnosed. Moreover, as per the IDF, Diabetes Atlas Tenth edition 2022, in the year 2023, more than 1.2 million children and adolescents (0-19 years) were living with Type 1 diabetes and one in six live births (21 million) were affected with diabetes during pregnancy. As per the above statistics, it can be concluded that the prevalence of diabetes mellitus in North America is increasing, this may increase the overall patient numbers suffering from the disease in the region, ultimately increasing the demand of clinical decision support systems. Thus, increasing the overall market growth of clinical decision support systems in the forecast period.

Furthermore, unhealthy life is contributing for an increase in the prevalence of chronic disease like cardiovascular disease and hypertension. Adults who eat a healthy diet life longer, have a lower risk of obesity, heart disease, type 2 diabetes, and certain cancers. Most Americans, however, do not follow a healthy lifestyle. As per the Center for Disease Control and Prevention (CDC), 2022, fewer than 1 in 10 adults and adolescents eat enough fruits and vegetables, and 9 in 10 Americans aged 20 years or older consume more than the recommended amount of sodium. The unhealthy lifestyle will increase the prevalence of chronic disorders in the forecast period owing to an increase the demand of clinical decision support systems in the North America market.

For instance, according to Government of Canada 2022, by the year 2030 seniors are expected to account for more than 9.5 million and make up 23% of Canadians. Moreover, as per the same source, by 2036, the average life expectancy at birth for women will rise to 86.2 years from the current 84.2 and to 82.9 years from the current life expentancy of 80 years for men. Geriatric patients are more susceptible to cancer and chronic ailments owing to the increased hospital admissions. This will increase the demand of the CDDS, thereby leading to the increase demand of the clinical decision support system.

Thus, all the above-mentioned factors are anticipated to propel the market for clinical decision support systems in the North America.

Clinical Decision Support Systems Market Key Players:

Some of the key market players operating in the clinical decision support systems market include Oracle, Epic Systems Corporation, IBM, Change Healthcare, Medical Information Technology, Inc., Koninklijke Philips N.V., Siemens Healthcare, Allscripts Healthcare Solutions Inc., Wolters Kluwer NV, Mckesson Corporation, Zynx Health Inc., Elsevier, NextGen Healthcare Inc., Agfa-Gevaert Group, Athenahealth Inc., VisualDx, naviHealth, Inc., CureMD Healthcare, Homecare Homebase, LLC., F. Hoffmann-La Roche Ltd., among others.

Recent Developmental Activities in the Clinical Decision Support Systems Market:

In April 2022, Change Healthcare, a leading healthcare technology company, released InterQual® 2022, the latest edition of the company's flagship clinical decision support solution for the delivery of the latest, evidence-based appropriate care. The release includes new criteria for emergent trends, restructured and interactive criteria to streamline workflows, and artificial intelligence (AI) to drive proactive insights and efficiency.

In October 2020, WeHealth Digital Medicine, Servier Group's e-health business unit, and CureMatch, a leader in digital health precision medicine, announced that they had received CE Mark approval for Bionov. Bionov is a clinical decision support software platform that provides healthcare professionals with personalized single drug and combination drug treatment options based on their cancer patients' molecular profiles.

In March 2020, IBM Watson Health and EBSCO Information Services announced a strategic collaboration aimed toward enhancing clinical decision support (CDS) and operations for healthcare providers and health systems.

Key Takeaways from the Clinical Decision Support Systems Market Report Study

• Market size analysis for current Clinical Decision Support Systems market size (2023), and market forecast for 5 years (2024-2030)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Clinical Decision Support Systems market.
• Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
• Key companies dominating the global Clinical Decision Support Systems market.
• Various opportunities available for the other competitor in the Clinical Decision Support Systems market space.
• What are the top performing segments in 2023? How these segments will perform in 2030.
• Which is the top-performing regions and countries in the current Clinical Decision Support Systems market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Clinical Decision Support Systems market growth in the coming future?

Target Audience who can be benefited from this Clinical Decision Support Systems Market Report Study

• Clinical Decision Support Systems products providers
• Research organizations and consulting companies
• Clinical Decision Support Systems-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in Clinical Decision Support Systems
• Various End-users who want to know more about the Clinical Decision Support Systems market and latest technological developments in the Clinical Decision Support Systems market.

Frequently Asked Questions for Clinical Decision Support Systems Market:

1. What are Clinical Decision Support Systems?

A clinical decision support system (CDSS), is a type of health information technology that provides knowledge and person-specific information to clinicians, staff, patients, and other individuals in order to improve health and health care. CDSS is a collection of tools designed to improve clinical decision-making. Among these tools are computerised alerts and reminders to care providers and patients, clinical guidelines, condition-specific order sets, focused patient data reports and summaries, documentation templates, diagnostic support, and contextually relevant reference information.

2. What is the market for Global Clinical Decision Support Systems?

Global clinical decision support systems (CDDS) market was valued at USD 2.23 billion in 2023, growing at a CAGR of 6.62% during the forecast period from 2024 to 2030 to reach USD 3.28 billion by 2030.

3. What are the drivers for the Global Clinical Decision Support Systems market?

The clinical decision support systems market is witnessing a positive market growth owing to the increasing patient pool globally. Advanced systems are required to manage the patients, leading to increased demand of the support system. Moreover, growing demand of intelligent software solutions in the healthcare industry and the rising demand for reducing healthcare expenditure will propel the market of clinical decision support system. Additionally, the surging need for improvement in the quality of care across the world are anticipated to bolster the market.

4. Who are the key players operating in the Global Clinical Decision Support Systems market?

Some of the key market players operating in the clinical decision support systems market include Oracle, Epic Systems Corporation, IBM, Change Healthcare, Medical Information Technology, Inc., Koninklijke Philips N.V., Siemens Healthcare, Allscripts Healthcare Solutions Inc., Wolters Kluwer NV, Mckesson Corporation, Zynx Health Inc., Elsevier, NextGen Healthcare Inc., Agfa-Gevaert Group, Athenahealth Inc., VisualDx, naviHealth, Inc., CureMD Healthcare, Homecare Homebase, LLC., F. Hoffmann-La Roche Ltd., and others.

5. Which region has the highest share in Clinical Decision Support Systems market?

North America is expected to hold the highest share in the revenue in the clinical decision support systems market during the forecast period. Increasing patient pool in the region and the rising need in the improvement in the quality of the care will propel the clinical decision support systems in the North America, leading to a rise in the overall clinical decision support systems market growth in this region.